Belite Deferred Long Term Liab vs Net Invested Capital Analysis

BLTE Stock

USD 63.26 4.18 6.20%

Belite Bio financial indicator trend analysis is way more than just evaluating Belite Bio ADR prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Belite Bio ADR is a good investment. Please check the relationship between Belite Bio Deferred Long Term Liab and its Net Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Belite Bio ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Deferred Long Term Liab vs Net Invested Capital

Deferred Long Term Liab vs Net Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Belite Bio ADR Deferred Long Term Liab account and Net Invested Capital. At this time, the significance of the direction appears to have pay attention.

The correlation between Belite Bio's Deferred Long Term Liab and Net Invested Capital is -0.89. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Net Invested Capital in the same time period over historical financial statements of Belite Bio ADR, assuming nothing else is changed. The correlation between historical values of Belite Bio's Deferred Long Term Liab and Net Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Belite Bio ADR are associated (or correlated) with its Net Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Invested Capital has no effect on the direction of Deferred Long Term Liab i.e., Belite Bio's Deferred Long Term Liab and Net Invested Capital go up and down completely randomly.

Correlation Coefficient

-0.89

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most indicators from Belite Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Belite Bio ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Belite Bio ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

As of November 30, 2024, Tax Provision is expected to decline to 5,225. In addition to that, Selling General Administrative is expected to decline to about 4.2 M

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	30K	198K	139K	105.6K
Interest Income	5K	23K	74K	77.7K

Depreciation And Amortization Interest Income

Belite Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Net Working Capital	Common Stock
Total Assets		-0.83	0.93	0.94	0.88	-0.56	0.84	-0.9	-0.89	1.0	0.86	0.04	-0.63	1.0	0.84	0.38	-0.83	0.91	0.88	-0.82	0.88	0.86	1.0	0.91	1.0	0.91
Short Long Term Debt Total	-0.83		-0.84	-0.89	-0.95	0.8	-0.96	0.96	0.93	-0.82	-0.89	-0.14	0.83	-0.82	-0.77	-0.03	1.0	-0.96	-0.94	1.0	-0.95	-0.97	-0.83	-0.96	-0.82	-0.96
Other Current Liab	0.93	-0.84		0.99	0.88	-0.78	0.84	-0.89	-0.94	0.92	0.91	0.39	-0.84	0.92	0.85	0.38	-0.84	0.91	0.89	-0.83	0.88	0.85	0.93	0.89	0.92	0.89
Total Current Liabilities	0.94	-0.89	0.99		0.9	-0.81	0.89	-0.91	-0.95	0.93	0.91	0.36	-0.86	0.93	0.83	0.3	-0.89	0.95	0.91	-0.88	0.9	0.9	0.93	0.93	0.92	0.93
Total Stockholder Equity	0.88	-0.95	0.88	0.9		-0.7	0.86	-1.0	-0.98	0.88	0.97	0.12	-0.76	0.88	0.93	0.34	-0.95	0.9	1.0	-0.94	1.0	0.87	0.88	0.89	0.88	0.89
Net Tangible Assets	-0.56	0.8	-0.78	-0.81	-0.7		-0.78	0.7	0.79	-0.54	-0.75	-0.69	1.0	-0.54	-0.56	0.05	0.8	-0.78	-0.73	0.79	-0.7	-0.78	-0.55	-0.75	-0.53	-0.75
Property Plant And Equipment Net	0.84	-0.96	0.84	0.89	0.86	-0.78		-0.88	-0.85	0.84	0.78	0.12	-0.81	0.84	0.64	-0.11	-0.96	0.98	0.85	-0.97	0.86	1.0	0.84	0.99	0.83	0.99
Net Debt	-0.9	0.96	-0.89	-0.91	-1.0	0.7	-0.88		0.98	-0.9	-0.97	-0.1	0.76	-0.9	-0.92	-0.32	0.96	-0.92	-1.0	0.95	-1.0	-0.89	-0.9	-0.91	-0.9	-0.91
Retained Earnings	-0.89	0.93	-0.94	-0.95	-0.98	0.79	-0.85	0.98		-0.88	-0.99	-0.3	0.84	-0.88	-0.94	-0.38	0.93	-0.9	-0.99	0.91	-0.98	-0.86	-0.88	-0.88	-0.87	-0.88
Cash	1.0	-0.82	0.92	0.93	0.88	-0.54	0.84	-0.9	-0.88		0.85	0.02	-0.62	1.0	0.83	0.39	-0.83	0.91	0.87	-0.82	0.88	0.86	1.0	0.9	1.0	0.9
Non Current Assets Total	0.86	-0.89	0.91	0.91	0.97	-0.75	0.78	-0.97	-0.99	0.85		0.31	-0.81	0.85	0.96	0.47	-0.89	0.84	0.98	-0.87	0.97	0.8	0.85	0.82	0.84	0.82
Non Currrent Assets Other	0.04	-0.14	0.39	0.36	0.12	-0.69	0.12	-0.1	-0.3	0.02	0.31		-0.66	0.02	0.18	0.14	-0.14	0.16	0.18	-0.12	0.12	0.12	0.02	0.11	0.01	0.11
Other Assets	-0.63	0.83	-0.84	-0.86	-0.76	1.0	-0.81	0.76	0.84	-0.62	-0.81	-0.66		-0.62	-0.63	-0.03	0.83	-0.82	-0.79	0.82	-0.76	-0.81	-0.62	-0.79	-0.61	-0.79
Cash And Short Term Investments	1.0	-0.82	0.92	0.93	0.88	-0.54	0.84	-0.9	-0.88	1.0	0.85	0.02	-0.62		0.83	0.39	-0.83	0.91	0.87	-0.82	0.88	0.86	1.0	0.9	1.0	0.9
Net Receivables	0.84	-0.77	0.85	0.83	0.93	-0.56	0.64	-0.92	-0.94	0.83	0.96	0.18	-0.63	0.83		0.66	-0.77	0.73	0.94	-0.76	0.93	0.66	0.83	0.7	0.83	0.7
Common Stock Shares Outstanding	0.38	-0.03	0.38	0.3	0.34	0.05	-0.11	-0.32	-0.38	0.39	0.47	0.14	-0.03	0.39	0.66		-0.04	0.05	0.36	-0.01	0.34	-0.08	0.38	0.01	0.39	0.01
Non Current Liabilities Total	-0.83	1.0	-0.84	-0.89	-0.95	0.8	-0.96	0.96	0.93	-0.83	-0.89	-0.14	0.83	-0.83	-0.77	-0.04		-0.96	-0.94	1.0	-0.95	-0.97	-0.83	-0.96	-0.82	-0.96
Other Current Assets	0.91	-0.96	0.91	0.95	0.9	-0.78	0.98	-0.92	-0.9	0.91	0.84	0.16	-0.82	0.91	0.73	0.05	-0.96		0.89	-0.95	0.9	0.99	0.91	1.0	0.91	1.0
Other Stockholder Equity	0.88	-0.94	0.89	0.91	1.0	-0.73	0.85	-1.0	-0.99	0.87	0.98	0.18	-0.79	0.87	0.94	0.36	-0.94	0.89		-0.94	1.0	0.86	0.87	0.88	0.87	0.88
Total Liab	-0.82	1.0	-0.83	-0.88	-0.94	0.79	-0.97	0.95	0.91	-0.82	-0.87	-0.12	0.82	-0.82	-0.76	-0.01	1.0	-0.95	-0.94		-0.94	-0.97	-0.82	-0.96	-0.81	-0.96
Net Invested Capital	0.88	-0.95	0.88	0.9	1.0	-0.7	0.86	-1.0	-0.98	0.88	0.97	0.12	-0.76	0.88	0.93	0.34	-0.95	0.9	1.0	-0.94		0.87	0.88	0.89	0.88	0.89
Property Plant And Equipment Gross	0.86	-0.97	0.85	0.9	0.87	-0.78	1.0	-0.89	-0.86	0.86	0.8	0.12	-0.81	0.86	0.66	-0.08	-0.97	0.99	0.86	-0.97	0.87		0.86	0.99	0.85	0.99
Total Current Assets	1.0	-0.83	0.93	0.93	0.88	-0.55	0.84	-0.9	-0.88	1.0	0.85	0.02	-0.62	1.0	0.83	0.38	-0.83	0.91	0.87	-0.82	0.88	0.86		0.9	1.0	0.9
Capital Stock	0.91	-0.96	0.89	0.93	0.89	-0.75	0.99	-0.91	-0.88	0.9	0.82	0.11	-0.79	0.9	0.7	0.01	-0.96	1.0	0.88	-0.96	0.89	0.99	0.9		0.9	1.0
Net Working Capital	1.0	-0.82	0.92	0.92	0.88	-0.53	0.83	-0.9	-0.87	1.0	0.84	0.01	-0.61	1.0	0.83	0.39	-0.82	0.91	0.87	-0.81	0.88	0.85	1.0	0.9		0.9
Common Stock	0.91	-0.96	0.89	0.93	0.89	-0.75	0.99	-0.91	-0.88	0.9	0.82	0.11	-0.79	0.9	0.7	0.01	-0.96	1.0	0.88	-0.96	0.89	0.99	0.9	1.0	0.9

Click cells to compare fundamentals

Belite Bio Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:

How To Invest In Belite

Details

Is Belite Stock a good investment?

Details

What is Belite Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Belite Bio ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.10)

Return On Assets

(0.26)

Return On Equity

(0.40)

The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Belite Deferred Long Term Liab vs Net Invested Capital Analysis

Deferred Long Term Liab vs Net Invested Capital

Deferred Long Term Liab vs Net Invested Capital Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Net Invested Capital

Belite Bio fundamental ratios Correlations

Belite Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total

Net Invested Capital	- 1.0	Net Debt
Other Stockholder Equity	- 1.0	Net Debt
Net Debt	- 1.0	Total Stockholder Equity
Other Stockholder Equity	- 0.99	Retained Earnings
Non Current Assets Total	- 0.99	Retained Earnings
Net Invested Capital	- 0.98	Retained Earnings